Government needs to take steps at home and in the European Union to ensure continued competitiveness of the sector
Ireland's biopharma and chemical industries, vital to the Irish economy, face challenges from global trade tensions, evolving regulations, and domestic infrastructure limitations. While the sector is optimistic, government action is needed to maintain competitiveness through infrastructure investment, increased research funding, and a balanced approach to EU regulations that supports innovation.
